Literature DB >> 230330

The demonstration of alpha lactalbumin in human breast carcinomas.

R A Walker.   

Abstract

Alpha lactalbumin, a good marker of functional differentiation, has been demonstrated in 51 of a 100 human breast carcinomas examined using the immunoperoxidase technique. There is no relationship between production of alpha lactalbumin and histological differentiation, and the absence or presence of lymph-node metastases.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 230330     DOI： 10.1002/path.1711290107

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


  10 in total

1.  Immunocytochemical detection of tumour markers in bone metastases from carcinoma of the breast.

Authors:  P Gugliotta; G Botta; G Bussolati
Journal:  Histochem J       Date:  1981-11

2.  Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study.

Authors:  F Wrba; E Ritzinger; A Reiner; J H Holzner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Correlation between laminin and type IV collagen distribution in breast carcinomas, and estrogen receptors expression, lymph node and vascular involvement.

Authors:  C Charpin; L Andrac; M C Habib; H Vacheret; M N Lavaut; L Xerri; D Figarella-Branger; P Casanova; M Toga
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive.

Authors:  W Domagala; M Markiewski; R Kubiak; J Bartkowiak; M Osborn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 5.  Transcriptionally targeted gene therapy to detect and treat cancer.

Authors:  Lily Wu; Mai Johnson; Makoto Sato
Journal:  Trends Mol Med       Date:  2003-10       Impact factor: 11.951

6.  Immunohistochemical markers in the identification of metastatic breast cancer.

Authors:  P C de Almeida; C B Pestana
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.

Authors:  C Charpin; J Jacquemier; L Andrac; H Vacheret; M C Habib; B Devictor; M N Lavaut; M Toga
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

8.  Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: an immunohistochemical study using the avidin-biotin-peroxidase complex method.

Authors:  C Charpin; P M Martin; A Lachard; J Jacquemier; M N Lavaut; C Andonian; N Pourreau-Schneider; M Toga
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

9.  A prophylactic vaccine for breast cancer? Why not?

Authors:  Vincent K Tuohy
Journal:  Breast Cancer Res       Date:  2010-12-08       Impact factor: 6.466

10.  Comparative functional histopathology of human breast carcinoma xenografts.

Authors:  M J Bailey; M G Ormerod; S F Imrie; J Humphreys; J D Roberts; J C Gazet; A M Neville
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.